Mineralocorticoid Receptor Antagonists—A New Sprinkle of Salt and Youth

Olivera Stojadinovic, Linsey E. Lindley, Ivan Jozic, Marjana Tomic-Canic

Research output: Contribution to journalComment/debate

4 Citations (Scopus)

Abstract

Skin atrophy and impaired cutaneous wound healing are the recognized side effects of topical glucocorticoid (GC) therapy. Although GCs have high affinity for the glucocorticoid receptor, they also bind and activate the mineralocorticoid receptor. In light of this, one can speculate that some of the GC-mediated side effects can be remedied by blocking activation of the mineralocorticoid receptor. Indeed, according to Nguyen et al., local inhibition of the mineralocorticoid receptor via antagonists (spironolactone, canrenoate, and eplerenone) rescues GC-induced delayed epithelialization and accelerates wound closure in diabetic animals by targeting epithelial sodium channels and stimulating keratinocyte proliferation. These findings suggest that the use of mineralocorticoid receptor antagonists coupled with GC therapy may be beneficial in overcoming at least some of the GC-mediated side effects.

Original languageEnglish (US)
Pages (from-to)1938-1941
Number of pages4
JournalJournal of Investigative Dermatology
Volume136
Issue number10
DOIs
StatePublished - Oct 1 2016

Fingerprint

Mineralocorticoid Receptors
Glucocorticoids
Salts
Mineralocorticoid Receptor Antagonists
Re-Epithelialization
Epithelial Sodium Channels
Skin
Spironolactone
Glucocorticoid Receptors
Keratinocytes
Wound Healing
Atrophy
Animals
Chemical activation
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Mineralocorticoid Receptor Antagonists—A New Sprinkle of Salt and Youth. / Stojadinovic, Olivera; Lindley, Linsey E.; Jozic, Ivan; Tomic-Canic, Marjana.

In: Journal of Investigative Dermatology, Vol. 136, No. 10, 01.10.2016, p. 1938-1941.

Research output: Contribution to journalComment/debate

Stojadinovic, Olivera ; Lindley, Linsey E. ; Jozic, Ivan ; Tomic-Canic, Marjana. / Mineralocorticoid Receptor Antagonists—A New Sprinkle of Salt and Youth. In: Journal of Investigative Dermatology. 2016 ; Vol. 136, No. 10. pp. 1938-1941.
@article{0839e72dbede4dae9025feb14e465b0a,
title = "Mineralocorticoid Receptor Antagonists—A New Sprinkle of Salt and Youth",
abstract = "Skin atrophy and impaired cutaneous wound healing are the recognized side effects of topical glucocorticoid (GC) therapy. Although GCs have high affinity for the glucocorticoid receptor, they also bind and activate the mineralocorticoid receptor. In light of this, one can speculate that some of the GC-mediated side effects can be remedied by blocking activation of the mineralocorticoid receptor. Indeed, according to Nguyen et al., local inhibition of the mineralocorticoid receptor via antagonists (spironolactone, canrenoate, and eplerenone) rescues GC-induced delayed epithelialization and accelerates wound closure in diabetic animals by targeting epithelial sodium channels and stimulating keratinocyte proliferation. These findings suggest that the use of mineralocorticoid receptor antagonists coupled with GC therapy may be beneficial in overcoming at least some of the GC-mediated side effects.",
author = "Olivera Stojadinovic and Lindley, {Linsey E.} and Ivan Jozic and Marjana Tomic-Canic",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.jid.2016.07.025",
language = "English (US)",
volume = "136",
pages = "1938--1941",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Mineralocorticoid Receptor Antagonists—A New Sprinkle of Salt and Youth

AU - Stojadinovic, Olivera

AU - Lindley, Linsey E.

AU - Jozic, Ivan

AU - Tomic-Canic, Marjana

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Skin atrophy and impaired cutaneous wound healing are the recognized side effects of topical glucocorticoid (GC) therapy. Although GCs have high affinity for the glucocorticoid receptor, they also bind and activate the mineralocorticoid receptor. In light of this, one can speculate that some of the GC-mediated side effects can be remedied by blocking activation of the mineralocorticoid receptor. Indeed, according to Nguyen et al., local inhibition of the mineralocorticoid receptor via antagonists (spironolactone, canrenoate, and eplerenone) rescues GC-induced delayed epithelialization and accelerates wound closure in diabetic animals by targeting epithelial sodium channels and stimulating keratinocyte proliferation. These findings suggest that the use of mineralocorticoid receptor antagonists coupled with GC therapy may be beneficial in overcoming at least some of the GC-mediated side effects.

AB - Skin atrophy and impaired cutaneous wound healing are the recognized side effects of topical glucocorticoid (GC) therapy. Although GCs have high affinity for the glucocorticoid receptor, they also bind and activate the mineralocorticoid receptor. In light of this, one can speculate that some of the GC-mediated side effects can be remedied by blocking activation of the mineralocorticoid receptor. Indeed, according to Nguyen et al., local inhibition of the mineralocorticoid receptor via antagonists (spironolactone, canrenoate, and eplerenone) rescues GC-induced delayed epithelialization and accelerates wound closure in diabetic animals by targeting epithelial sodium channels and stimulating keratinocyte proliferation. These findings suggest that the use of mineralocorticoid receptor antagonists coupled with GC therapy may be beneficial in overcoming at least some of the GC-mediated side effects.

UR - http://www.scopus.com/inward/record.url?scp=84996956048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996956048&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2016.07.025

DO - 10.1016/j.jid.2016.07.025

M3 - Comment/debate

VL - 136

SP - 1938

EP - 1941

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 10

ER -